Ligand Pharmaceuticals (United States)

511 papers and 34.5k indexed citations i.

About

In recent decades, authors affiliated with Ligand Pharmaceuticals (United States) have published 511 papers, which have received a total of 34.5k indexed citations. Scholars at this organization have produced 293 papers in Molecular Biology, 208 papers in Genetics and 88 papers in Oncology on the topics of Estrogen and related hormone effects (194 papers), Retinoids in leukemia and cellular processes (161 papers) and Antioxidant Activity and Oxidative Stress (44 papers). Their work is cited by papers focused on Molecular Biology (20.5k citations), Genetics (10.2k citations) and Oncology (6.0k citations). Authors at Ligand Pharmaceuticals (United States) collaborate with scholars in United States, France and United Kingdom and have published in prestigious journals including Nature, Science and Cell. Some of Ligand Pharmaceuticals (United States)'s most productive authors include Richard A. Heyman, Ronald M. Evans, David J. Mangelsdorf, Robert B. Stein, Daniel J. Noonan, William W. Lamph, Donald P. McDonnell, A. Negro‐Vilar, Mark E. Goldman and Steven A. Kliewer.

In The Last Decade

Fields of papers published by authors at Ligand Pharmaceuticals (United States)

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Ligand Pharmaceuticals (United States) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Ligand Pharmaceuticals (United States) at the time of their publication.

Countries citing scholars working at Ligand Pharmaceuticals (United States)

Since Specialization

Citations

This map shows the geographic impact of research produced by authors working at Ligand Pharmaceuticals (United States). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Ligand Pharmaceuticals (United States) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ligand Pharmaceuticals (United States) more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore institutions with similar magnitude of impact

Breakdown of academic impact, for scholars at Intelligent Synthetic Biology Center Breakdown of academic impact, for scholars at Guttmacher Institute Breakdown of academic impact, for scholars at The National Databank for Rheumatic Diseases Breakdown of academic impact, for scholars at La Jolla Bioengineering Institute Breakdown of academic impact, for scholars at Parkinson's UK Breakdown of academic impact, for scholars at Center for Surveillance, Epidemiology, and Laboratory Services Breakdown of academic impact, for scholars at Fujirebio (Belgium) Breakdown of academic impact, for scholars at Naval Research Laboratory Center for Bio/Molecular Science and Engineering